Abstract  Description  Claims  Drawing  Search report  Cited references 

US60841437B   [0001] 
US6897224B   [0054] 
US6903215B   [0054] 
US6960581B   [0054] 
US20060116396A   [0054]  [0085] 
WO2006050998A1A   [0054] 
US20040029932A   [0085] 
US20040162321A   [0085] 
US20040224992A   [0085] 
US20050059714A   [0085] 
US20050176706A   [0085] 
US20050203128A   [0085] 
US20050234091A   [0085] 
US20050282881A   [0085] 
US20060014787A   [0085] 
US20060030561A   [0085] 
US6242196B   [0092] 
US6316465B   [0092] 
US5378475A   [0137] 
US5773019A   [0137] 
US5902598A   [0137] 
US6001386A   [0137] 
US6051576A   [0137] 
US6726918B   [0137] 
US20040219512A   [0146] 

Curr. Med. Chem.-Central Nervous System Agents   [0004] 
Antioxidants & Redox Signaling   [0005] 
Curr. Drug Target-Inflam. & Allergy   [0005] 
Mutat. Res.   [0005] 
Expt'l Eye Res.   [0006] 
Invest. Ophthalmol. & Vis. Sci.   [0006] 
Clin. Sci.   [0039] 
Mol. Endocrinol.   [0039] 
New Engl. J. Med.   [0039] 
Pharmacol. Ther.   [0039] 
Nature   [0092] 
Horm. Metab. Res.   [0092] 
J. Biol. Chem.   [0092] 
The Complete Drug Reference   [0104] 
The Science and Practice of Pharmacy   [0104] 
Prostaglandin and non prostaglandin-mediated breakdown of the blood-aqueous barrier   [0192] 
The site of action of prostaglandin E2 on the disruption of the blood-aqueous barrier in the rabbit eye   [0192] 
Disruption of the blood-aqueous barrier following paracentesis in the rabbit   [0192] 
Autacoids and Neuropeptides.   [0192] 
Quantification of ocular inflammation: evaluation of polymorphonuclear leukocyte infiltration by measuring myeloperoxidase activity   [0192]